Ardelyx (ARDX) EBT Margin (2013 - 2026)

Ardelyx's (ARDX) quarterly EBT Margin came in at 39.8% in Q1 2026, up 1456.0% YoY from 2.56% in Q1 2025, and down 12357.81% on a QoQ basis from 0.32% in Q4 2025.

Ardelyx (ARDX) EBT Margin (2013 - 2026) Analysis & Trends

Ardelyx (ARDX) has 12 years of EBT Margin data on file, last reported at 39.8% in Q1 2026.

  • Quarterly EBT Margin rose 1456.0% year-over-year to 39.8% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 18.06% (down 348.0% YoY) and the FY2025 annual result came in at 14.89%, down 323.0% from the prior year.
  • EBT Margin fell to 39.8% in Q1 2026, from 0.32% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 24.21% in Q4 2022 to a low of 5997.65% in Q1 2022.
  • A 5-year average of 476.33% and a median of 39.8% in 2026 frame the typical range for EBT Margin.
  • Annual changes were most pronounced in 2022 — EBT Margin tumbled 549394 bps — and 2023, when it soared 576228 bps.
  • Tracing ARDX's EBT Margin over 5 years: stood at 24.21% in 2022, then sank by 442 bps to 82.85% in 2023, then soared by 105 bps to 4.03% in 2024, then tumbled by 108 bps to 0.32% in 2025, then tumbled by 12358 bps to 39.8% in 2026.
  • The last three EBT Margin figures came in at 39.8% (Q1 2026), 0.32% (Q4 2025), and 25.5% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 35.61%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 34.77%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 18.33%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -94.22%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 12.09%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 13.77%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -2.67%
10 Ardelyx 1.01 Bn 729.71 Mn 115.12 Mn -13.74%

Historic Data

Download Data
DateValue
Jun 30, 2026 -13.74%
Mar 31, 2026 -39.80%
Dec 31, 2025 -0.32%
Sep 30, 2025 -25.50%
Jun 30, 2025 -19.53%
Mar 31, 2025 -54.36%
Dec 31, 2024 4.03%
Sep 30, 2024 -0.78%
Jun 30, 2024 -22.38%
Mar 31, 2024 -57.36%
Dec 31, 2023 -82.85%
Sep 30, 2023 12.11%
Jun 30, 2023 -76.66%
Mar 31, 2023 -235.37%
Dec 31, 2022 24.21%
Sep 30, 2022 -459.15%
Jun 30, 2022 -1,066.19%
Mar 31, 2022 -5,997.65%
Dec 31, 2021 -3,521.28%
Sep 30, 2021 -3,715.77%